News
Days after Elevance Health assured investors it remains optimistic about Medicare Advantage, the health insurance company announced it will stop marketing most products under the program.
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results tomorrow before market hours. Here’s what to look for. Elevance Health met analysts’ revenue expectations last ...
Gail Boudreaux; President, Chief Executive Officer, Director; Elevance Health Inc Mark Kaye; Chief Financial Officer, Executive Vice President; Elevance Health Inc Peter Haytaian; Executive Vice ...
INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Elevance Health Inc. (ELV) on Tuesday reported first-quarter earnings of $2.18 billion. The Indianapolis-based company said it had profit of $9.61 per ...
Elevance Health posted $418 million in profit for the fourth quarter of 2024 and earned $45 billion in revenue in the quarter. For full-year 2024, Elevance reported $175.2 billion in revenue, an ...
Elevance Health, Inc.'s Q1 results showed stable Medicare utilization and reaffirmed guidance, in contrast to sector volatility following UnitedHealth Group's rough earnings miss. Medicaid ...
Elevance Health lowered its profit guidance but held tight on its adjusted earnings target for the year after higher yields and more members boosted first-quarter revenue. The insurer said it now ...
ELEVANCE HEALTH ($ELV) is expected to release its quarterly earnings data on Tuesday, April 22nd before market open, per Finnhub. Analysts are expecting revenue of ...
Elevance Health Stock Up 0.3 % Elevance Health stock opened at $441.02 on Tuesday. The stock has a 50 day moving average of $413.71 and a two-hundred day moving average of $411.99. Elevance Health ...
Understanding the importance of community pharmacists in healthcare, Elevance Health and their PBM, CarelonRx, have partnered with CPESN USA pharmacies since 2021 to support Medicaid members in ...
Elevance Health Inc. reported robust financial results for Q1 2025, surpassing Wall Street’s expectations with an adjusted EPS of $11.97, compared to a forecast of $11.08. The company’s revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results